chr9-101362734-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_001701.4(BAAT):​c.951G>A​(p.Gln317Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00644 in 1,614,218 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0067 ( 43 hom. )

Consequence

BAAT
NM_001701.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.705

Publications

2 publications found
Variant links:
Genes affected
BAAT (HGNC:932): (bile acid-CoA:amino acid N-acyltransferase) The protein encoded by this gene is a liver enzyme that catalyzes the transfer of C24 bile acids from the acyl-CoA thioester to either glycine or taurine, the second step in the formation of bile acid-amino acid conjugates. The bile acid conjugates then act as a detergent in the gastrointestinal tract, which enhances lipid and fat-soluble vitamin absorption. Defects in this gene are a cause of familial hypercholanemia (FHCA). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
BAAT Gene-Disease associations (from GenCC):
  • hypercholanemia, familial 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • bile acid CoA:amino acid N-acyltransferase deficiency
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • familial hypercholanemia
    Inheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Laboratory for Molecular Medicine
  • bile acid conjugation defect 1
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 9-101362734-C-T is Benign according to our data. Variant chr9-101362734-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 197199.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.705 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 5 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BAATNM_001701.4 linkc.951G>A p.Gln317Gln synonymous_variant Exon 4 of 4 ENST00000259407.7 NP_001692.1 Q14032
BAATNM_001127610.2 linkc.951G>A p.Gln317Gln synonymous_variant Exon 4 of 4 NP_001121082.1 Q14032
BAATNM_001374715.1 linkc.951G>A p.Gln317Gln synonymous_variant Exon 4 of 4 NP_001361644.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BAATENST00000259407.7 linkc.951G>A p.Gln317Gln synonymous_variant Exon 4 of 4 1 NM_001701.4 ENSP00000259407.2 Q14032

Frequencies

GnomAD3 genomes
AF:
0.00388
AC:
590
AN:
152226
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00227
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00723
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00413
AC:
1037
AN:
251064
AF XY:
0.00414
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00130
Gnomad ASJ exome
AF:
0.000993
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00286
Gnomad NFE exome
AF:
0.00725
Gnomad OTH exome
AF:
0.00392
GnomAD4 exome
AF:
0.00670
AC:
9799
AN:
1461874
Hom.:
43
Cov.:
33
AF XY:
0.00647
AC XY:
4702
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.000896
AC:
30
AN:
33480
American (AMR)
AF:
0.00125
AC:
56
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.000880
AC:
23
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39696
South Asian (SAS)
AF:
0.00154
AC:
133
AN:
86258
European-Finnish (FIN)
AF:
0.00277
AC:
148
AN:
53420
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.00817
AC:
9088
AN:
1112002
Other (OTH)
AF:
0.00510
AC:
308
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
731
1462
2192
2923
3654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
346
692
1038
1384
1730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00387
AC:
590
AN:
152344
Hom.:
5
Cov.:
32
AF XY:
0.00368
AC XY:
274
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41574
American (AMR)
AF:
0.000980
AC:
15
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4834
European-Finnish (FIN)
AF:
0.00179
AC:
19
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00723
AC:
492
AN:
68034
Other (OTH)
AF:
0.00473
AC:
10
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
34
67
101
134
168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00479
Hom.:
4
Bravo
AF:
0.00366
EpiCase
AF:
0.00562
EpiControl
AF:
0.00545

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 08, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BAAT: BP4, BP7, BS2 -

Hypercholanemia, familial 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
6.5
DANN
Benign
0.72
PhyloP100
-0.70
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.20
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.20
Position offset: -23

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61756326; hg19: chr9-104125016; API